医学
闭塞
荟萃分析
科克伦图书馆
动脉瘤
外科
随机对照试验
剪裁(形态学)
内科学
语言学
哲学
作者
Ali Mortezaei,Forough Yazdanian,Mohammad Mirahmadi Eraghi,Farid Qoorchi Moheb Seraj,Rômulo Augusto Andrade de Almeida,Parsa Saberian,Mohammad Amin Habibi,Justin H. Granstein,Humain Baharvahdat,Redi Rahmani,Robert M Starke
标识
DOI:10.1007/s10143-025-03532-y
摘要
Abstract Woven Endo Bridge (WEB) is a flow diverter device used to treat wide-necked intracranial aneurysms. We conducted a systematic review and meta-analysis to determine the retreatment rate and strategies following aneurysmal recurrence after WEB treatment. A systematic literature search was conducted through four electronic databases. The Cochrane risk of bias tool for non-randomized trials (ROBINS-I) was used for risk of bias assessment. A meta-analysis and meta-regression were performed on relevant variables. A total of 29 studies with 2067 patients were included. Initially treated aneurysms had an adequate occlusion rate of 84.7% (20 studies, 980/1156, 95%CI: 79%—89%) at the last follow-up. The overall retreatment rate was 8.6% (24 studies, 251/2893, 95%CI: 6.5%—10.9%). Following retreatment, the immediate complete occlusion rate post retreatment and complete occlusion rate at last follow-up were 52% (six studies, 95%CI, 11%—91%) and 65% (six studies, 77/120, 95%CI: 56%—73%) respectively. Stent-assisted coiling achieved a 100% (95%CI: 57%—100%, P-value < 0.01) immediate adequate occlusion rate and 74% complete occlusion rate (95%CI: 16%—100%, P -value = 0.63) at last follow-up, which was higher than clipping, coiling, and flow diversion. On meta-regression, aneurysm height and neck width significantly associated with higher retreatment rate. The current meta-analysis showed a 9% retreatment rate after initial aneurysms treatment with WEB and overall adequate retreatment occlusion was high. Although stent-assisted coiling showed a higher adequate occlusion rate post-operatively, there was no significant difference between retreatment strategies in long-term radiological outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI